Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Daniel Willis
Pye to step down as Benchmark CEO, search begins for replacement
Benchmark founder Malcolm Pye will step down as chief executive later this year.
ImmuCell shares fall to two-year low following weak Q2
US company ImmuCell has seen its share price drop to its lowest level since 2017.
Novozymes appoints financial veteran EVP, CFO
Danish biotechnology company Novozymes has appointed Lars Green to the role of executive vice president and corporate finance officer.
BV Science boosts European presence with new distribution site
US feed additives firm BV Science has increased its presence in Europe after opening a new distribution center in Budapest, Hungary.
Elanco share price falls following second quarter, week of rumors
Elanco has seen its share price decline following its second-quarter results.
Better Choice to assess CBD efficacy in treating canine anxiety
US pet health specialist Better Choice is working on clinical studies on the potential of cannabidiol (CBD) products to reduce anxiety in dogs.